Related Experiment Video
Updated: May 6, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
9.9K
Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations
1Dermatology Branch, Division of Clinical Sciences, National Cancer Institute, Bldg 10, Room 12N238, National Institutes of Health, 10 Center Dr, MSC 1908, Bethesda, MD 20892-1908, USA. Kim_B_Yancey@nih.gov
JAMA
|July 13, 2000
Summary
Autoimmune blistering diseases involve autoantibodies targeting skin adhesion proteins, leading to blistering. Treatment with immunosuppressives has improved patient outcomes and reduced disease severity.
Area of Science:
- Dermatology
- Immunology
- Pathology
Background:
- Autoimmune blistering diseases are distinct conditions with specific clinical, histologic, and immunopathologic features.
- These disorders impair epidermal adhesion, either to the basement membrane (pemphigoid group) or between cells (pemphigus group).
Observation:
- Autoantibodies in these diseases have demonstrated pathogenic, blister-forming activity in passive transfer models.
- The autoantigens are crucial structural proteins responsible for cell-matrix and cell-to-cell adhesion in the skin.
Findings:
- Autoimmune blistering diseases are linked to significant morbidity, including pruritus, pain, and disfigurement.
- Mortality can occur due to the loss of epidermal barrier function.
Implications:
- Systemic immunosuppressive therapy has proven effective in mitigating the morbidity and mortality associated with these conditions.
- Understanding autoantigen targets offers insights into disease mechanisms and potential therapeutic strategies.
Related Concept Videos
01:05Desmosomes
7.5K
The term desmosome derives from the Greek words "desmo" and "soma" meaning "adhesion bodies." This structure was first observed during the late 1800s and described as small, dense nodules in the epidermis. Desmosomes are button-like structures that help form an interlinked network of intermediate filaments across the cells. These junctions are essential to hold cells together under mechanical stress and to maintain tissue integrity. Desmosomes are multi-protein...
7.5K
01:14Changes in Skin Color: Clinical Perspectives
3.6K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.6K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
780
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
780
01:23Gastritis III: Clinical Manifestations and Management
1.9K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
1.1K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
1.1K
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
64
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64